in

The world’s third largest manufacturer of generic drugs: Actavis (ACT)-delisting (1983)

Actavis plc (NYSE:ACT) was established in 1983 and is headquartered in Parsippany, New Jersey, USA. It has 21,600 full-time employees. It is a professional pharmaceutical company integrating development, production, sales and distribution, focusing on Used in the production and sales of generic drugs and over-the-counter drugs.

Actavis logo

Actavis (ACT):

Actavis Group is a pharmaceutical company headquartered in New Jersey, USA. It ranks among the top 50 global pharmaceutical companies. After the merger of Actavis and Watson, the new group has become the world’s third largest manufacturer of generic drugs. The business covers more than 100 countries or regions around the world. At present, there are more than 1,000 products in production and sales, and more than 600 products under development and registration, covering various fields such as central nervous system, digestion, cardiovascular, metabolism, anti-infection, and respiratory.

Acton’s products include: Dalvance, Bystolic, Canasa, Carafate, Daliresp, Fetzima, Linzess, Namenda, Namenda XR, Saphris, Teflaro, Viibryd, Actonel, Asacol HD, Atelvia, Delzicol, Doryx, Estrace Cream, Enablex, Lo There are many brands such as Loestrin Fe, Minastrin, etc.

Actavis’s factory in China is located in Foshan, Guangdong. It currently has antibiotics, digestive system, cardiovascular and vitamin drugs, including tablets, soft capsules, hard capsules, oral liquids, dry suspensions, ointments, There are 118 varieties of liniment and various dosage forms, with an annual production capacity of 2 billion tablets, 1 billion hard capsules and soft capsules.

In January 2014, Actavis Group (Actavis) CEO Paul Bizarro announced: “Because the Chinese market environment is very difficult for the company to conduct business, the company intends to completely withdraw from the Chinese market.”

Actavis (ACT) investment:

March 17, 2015, ACT completed a global medical beauty industry leader Al Kin acquisition, thus becoming Cosmetics & beauty products industry leader. At present, it is a super pharmaceutical & medical beauty leader with a market value of over 100 billion U.S. dollars, second only to a group of super giants such as Pfizer , Johnson & Johnson , GlaxoSmithKline , Merck , and Novartis . After the acquisition, the company changed its name to: Allergan, plc, and its stock code was changed to: AGN.

Actavis official website: www.actavis.com

Actavis Chinese Encyclopedia: www.thisyear.com

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all Intels

One of the world’s largest chemical companies: DuPont de Nemours, Inc. (DD) (1802)

One of the world’s six largest petrochemical companies: BP plc (BP) (1889)